Latest Rodenticides Stories

2011-01-03 15:08:54

Researchers from Boston University School of Medicine (BUSM) and the Bedford VA Medical Center believe that risk-adjusted percent time in therapeutic range (TTR) should be used as part of an effort to improve anticoagulation control and thus improve patient outcomes. These findings appear in this month's issue of Circulation: Cardiovascular Quality and Outcomes. Oral anticoagulation with warfarin is received by millions of Americans each year to treat blood clots and to prevent strokes. While...

2010-11-16 00:00:49

Wool.labs, a business intelligence company driven by social cognition technology, has published a revealing study through SmartBrief, showing confusion among patients and disagreement among physician specialties about the appropriate use of anticoagulants such as Coumadin. The study found that patients steadily increased their self-education efforts from 1999 through 2010 due to differing physician attitudes towards treatment and inconsistent information. Wayne, Pa. (PRWEB) November 15, 2010...

2010-11-15 19:44:30

Increased communication between doctors and patients is key, say researchers at Intermountain Medical Center Heart Institute in Salt Lake City Herbal and dietary supplements are popular. People claim they make their joints feel better, their bones stronger, and their hearts healthier. But a recent study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City shows that many of these people may not realize their favorite supplement, mixed with prescription...

2010-04-07 14:02:00

OAKLAND, Calif., April 7 /PRNewswire/ -- Machaon Diagnostics, California's only independent laboratory for testing bleeding and clotting disorders has launched a clinical testing service for patients that have been prescribed warfarin. Warfarin, also known as Coumadin, Jantoven or warfarin sodium, is a potent 'blood thinner' or anticoagulant. Machaon's FDA-approved array-based technology detects genetic variations in 2 key genes involved in the metabolism of warfarin. 40% of the general...

2010-03-16 07:01:00

ATLANTA, March 16 /PRNewswire-FirstCall/ -- Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.-- in association with the Medco Research Institute(TM) -- and Mayo Clinic announced today. Results of the first nationwide prospective study examining outcomes when incorporating genetic...

2010-03-08 13:16:42

Children with serious intestinal problems have to be fed intravenously. There moreover, exist systems that enable intravenous feeding to be carried out at home. Mr Iñaki Irastorza, pediatrician at the Cruces hospital in Bilbao, spent some 15 years analyzing how serious intestinal problems in children were treated at the Great Ormond Street Children's Hospital in London. With the gathered data he has presented a highly novel PhD thesis at the University of the Basque...

2009-10-15 11:15:00

National Trauma Databank researchers find elderly patients more vulnerable to problems CHICAGO, Oct. 15 /PRNewswire-USNewswire/ -- A common drug used for preventing heart attacks and blood clots may also cause problems for individuals who suffer some form of trauma, particularly elderly patients, according to a study presented today at the 2009 Clinical Congress of the American College of Surgeons. The study findings could have implications for how doctors prescribe warfarin as use of...

2009-07-15 07:30:00

BOSTON and EDISON, N.J., July 15 /PRNewswire/ -- A sub-analysis of a Phase IIb multinational study(1) with edoxaban(2) - an investigational oral Factor Xa inhibitor - provides insights into why patients with non-valvular atrial fibrillation (AF) receiving edoxaban once daily (QD) experienced fewer bleeding events than patients given edoxaban twice a day (BID). The analysis finds that bleeding associated with edoxaban is most closely correlated with minimum concentration levels of the drug...

2009-03-20 15:20:00

Researchers at Uppsala University, together with colleagues at the Karolinska Institute and the Sanger Institute, have now found all the genes the determine the dosage of the blood-thinning drug warfarin. The findings are published in the scientific journal PLoS Genetics. "We have previously studied selected genes that can affect warfarin treatment. Now that we have gone in and scanned the entire genome, we see that the two most important genes are among those we previously singled out," says...

2009-02-19 14:31:06

A new formula that involves gene testing could equip doctors with a better means of gauging the dosage of the common blood-thinning drug warfarin, according to a new large-scale study. Warfarin is one of the most widely prescribed drugs in the world "“ an estimated 2 million Americans with heart conditions or other risk factors begin taking the drug each year "“ but doctors currently use a method of trial and error to determine how much a patient should be taking. This method...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'